文献速递肝胆胰外科急腹症与外科感染围术期管理与 ERAS

内镜对比手术治疗感染性坏死性胰腺炎:随机对照试验的系统综述与荟萃分析

Endoscopic versus surgical treatment for infected necrotizing pancreatitis: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Surg Endosc · 2020-02-28

该系统综述与荟萃分析纳入3项随机对照试验共190例感染性包裹性坏死患者,比较内镜与手术治疗。意向治疗分析显示两组死亡率无差异,但内镜组新发多器官衰竭、内脏穿孔或肠皮瘘及胰瘘的几率显著更低,平均住院时间显著缩短。证据总体确定性为中等,因手术组术式异质性及随机证据有限,需进一步研究。

要点

  • 内镜治疗与手术治疗的死亡率无显著差异。
  • 内镜组新发多器官衰竭、内脏穿孔或肠皮瘘及胰瘘的几率显著更低。
  • 内镜组平均住院时间显著缩短,但证据确定性为中等。

核心结论

  • 内镜治疗感染性坏死性胰腺炎可能具有获益,但需进一步研究评估不同方法组合及干预时机。

研究设计与样本

  • 遵循Cochrane和PRISMA指南及AMSTAR-2标准检索CENTRAL、Medline和Web of Science的系统综述与荟萃分析。
  • 纳入比较内镜与手术治疗感染性包裹性坏死的随机对照试验,共3项RCT、190例患者。

主要发现

  • 意向治疗分析显示两组死亡率无差异。

关键数值与推荐

  • 需干预的出血、切口疝、外分泌或内分泌功能不全及ICU住院时间两组无差异。
  • 证据总体确定性为中等。

临床怎么用

  • 对于感染性包裹性坏死,内镜治疗可作为优先考虑的策略之一,尤其关注降低新发多器官衰竭、穿孔/瘘和胰瘘风险。

局限性

  • 手术组术式存在异质性。
  • 随机对照证据数量较少(仅3项RCT、190例患者)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes of endoscopic and surgical treatment for infected necrotizing pancreatitis (INP) based on results of randomized controlled trials (RCT). BACKGROUND: Treatment of INP has changed in the last two decades with adoption of interventional, endoscopic and minimally invasive surgical procedures for drainage and necrosectomy. However, this relies mostly on observational studies. METHODS: We performed a systematic review following Cochrane and PRISMA guidelines and AMSTAR-2 criteria and searched CENTRAL, Medline and Web of Science. Randomized controlled trails that compared an endoscopic treatment to a surgical treatment for patients with infected walled-off necrosis and included one of the main outcomes were eligible for inclusion. The main outcomes were mortality and new onset multiple organ failure. Prospero registration ID: CRD42019126033 RESULTS: Three RCTs with 190 patients were included. Intention to treat analysis showed no difference in mortality. However, patients in the endoscopic group had statistically significant lower odds of experiencing new onset multiple organ failure (odds ratio (OR) confidence interval [CI] 0.31 [0.10, 0.98]) and were statistically less likely to suffer from perforations of visceral organs or enterocutaneous fistulae (OR [CI] 0.31 [0.10, 0.93]), and pancreatic fistulae (OR [CI] 0.09 [0.03, 0.28]). Patients with endoscopic treatment had a statistically significant lower mean hospital stay (Mean difference [CI] - 7.86 days [- 14.49, - 1.22]). No differences in bleeding requiring intervention, incisional hernia, exocrine or endocrine insufficiency or ICU stay were apparent. Overall certainty of evidence was moderate. CONCLUSION: There seem to be possible benefits of endoscopic treatment procedure. Given the heterogenous procedures in the surgical group as well as the low amount of randomized evidence, further studies are needed to evaluate the combination of different approaches and appropriate timepoints for interventions.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Haney CM, Kowalewski KF, Schmidt MW, et al. Endoscopic versus surgical treatment for infected necrotizing pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Surg Endosc. 2020. PMID: 32112252. doi:10.1007/s00464-020-07469-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。